Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 93 articles: HTML format

Single Articles

January 2026
1. BAGULEY E, Knaub M, VanDyke J, Hirschfield G, et al
   Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study.
   PLoS One. 2026;21:e0340475.
   PubMed     Abstract available
   
   
   
2. ZHANG C, Liang H, Qin Y, Tan X, et al
   A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives.
   PLoS One. 2026;21:e0341154.
   PubMed     Abstract available
   
   
   
3. PARK Y, Kim KS, Jo H, Kim HP, et al
   Feasibility of tumor-informed circulating tumor DNA for detecting minimal residual disease in surgically resected biliary tract cancer.
   PLoS One. 2026;21:e0341432.
   PubMed     Abstract available
   
   
   
4. CHUEAJEDTON K, Chueaiphuk C, Inpad J, Kumphune S, et al
   Secretory leukocyte protease inhibitor (SLPI) promotes cholangiocarcinoma progression via inflammation-associated and vasculogenic mechanisms.
   PLoS One. 2026;21:e0340763.
   PubMed     Abstract available
   
   
   
5. FABIAN O, Bajer L, Macinga P, Brezina J, et al
   Identifying biomarkers for diagnosis and disease activity monitoring in PSC-IBD and UC through proteomic profiling: A prospective, biomarker discovery single-center study protocol.
   PLoS One. 2026;21:e0341885.
   PubMed     Abstract available
   
   
   
6. KITAGATAYA T, Krishnan A, Olson KE, Gutierrez F, et al
   Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury.
   PLoS One. 2026;21:e0342251.
   PubMed     Abstract available
   
   
   
7. CHEN R, Sun Y, Tai W
   A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis.
   PLoS One. 2026;21:e0342306.
   PubMed     Abstract available
   
   
   
8. XI J, Wang S, Chen J, Law JCS, et al
   Exploration and discovery of treatment targets for primary biliary cholangitis based on plasma and cerebrospinal fluid proteomics: A multicenter mendelian randomization study.
   PLoS One. 2026;21:e0340166.
   PubMed     Abstract available
   
   
   
9. ARTBUA P, Kentachalee N, Sitthirak S, Sa-Ngiamwibool P, et al
   Prognostic value of cGAS-STING-IRF3 signaling in cholangiocarcinoma patients.
   PLoS One. 2026;21:e0342756.
   PubMed     Abstract available
   
   
   
10. LI T, ZhenYu J, Jing W
    Evaluation of the mechanism underlying melatonin action in cholestatic liver disease treatment via network pharmacology, molecular docking, and in vivo experiments.
    PLoS One. 2026;21:e0342978.
    PubMed     Abstract available
    
    
    
11. IBI Y, Omori T
    Cure rate estimation with insufficient follow-up: A median-based bootstrap correction approach.
    PLoS One. 2026;21:e0344669.
    PubMed     Abstract available
    
    
    
12. LEI Y, Ma X, Jin X, He Y, et al
    Huanggan decoction ameliorates cholestatic hepatic fibrosis in rats via TGF-beta1/Smad3 signaling pathway.
    PLoS One. 2026;21:e0344168.
    PubMed     Abstract available
    
    
    
13. CHOI SJ, Kim HJ, Kwon SW, Kim WS, et al
    Lipidomic analysis of bile from patients with extrahepatic cholangiocarcinoma.
    PLoS One. 2026;21:e0345136.
    PubMed     Abstract available
    
    
    
14. SORNSENEE P, Chaochuensuk C, Sapsong D, Khongchuy K, et al
    Development and internal validation of a risk stratification scoring system for identifying gram-negative ESBL-positive acute cholangitis: A retrospective cohort study.
    PLoS One. 2026;21:e0345150.
    PubMed     Abstract available
    
    
    
15. FAN R, Cao X, Long Z, Ma B, et al
    Prevalence and risk factors of cholelithiasis in patients with spinal cord injury: A cross-sectional analysis.
    PLoS One. 2026;21:e0344816.
    PubMed     Abstract available
    
    
    
16. ALZOUBI M, Omar Saleh A, Omari FA, Shatnawi K, et al
    Asymptomatic gallstones: Cumulative incidence proportion, incidence rate, and risk factors for symptoms development: Systematic review and meta-analysis.
    PLoS One. 2026;21:e0345462.
    PubMed     Abstract available
    
    
    
17. AOTO K, Inose R, Muraki Y
    Clinical impact of broad- versus narrow-spectrum empiric therapy in acute cholangitis: A Japanese claims database study.
    PLoS One. 2026;21:e0346452.
    PubMed     Abstract available
    
    
    January 2025
18. SUGAWARA I, Kawahara Y, Takayasu L, Isshi K, et al
    Study on the relationship between microbial composition within obstructive biliary stents and the severity of obstruction and duration of stent placement.
    PLoS One. 2025;20:e0317230.
    PubMed     Abstract available
    
    
    
19. SAWAYA M, Cordina-Duverger E, Lamy PJ, Tretarre B, et al
    Kidney and gallbladder stones and the risk of prostate cancer: Results from the EPICAP study.
    PLoS One. 2025;20:e0317760.
    PubMed     Abstract available
    
    
    
20. ARMARTMUNTREE N, Kittirat Y, Promraksa B, Loilome W, et al
    Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells.
    PLoS One. 2025;20:e0317111.
    PubMed     Abstract available
    
    
    
21. THAKUR C, Mahato RK, Marasini S, Timalsena D, et al
    Risk factors of gallbladder cancer in Nepal: A case control study.
    PLoS One. 2025;20:e0317249.
    PubMed     Abstract available
    
    
    
22. WANG F, Gao Y
    Efficacy of early enteral nutrition support on the nutritional status of patients after gallstone surgery.
    PLoS One. 2025;20:e0314659.
    PubMed     Abstract available
    
    
    
23. HASAN R, Allahbakhshi F, Shlyk AD, Allahbakhshi K, et al
    Gallstones as a predictor of elevated cardiovascular disease risk: A meta-analysis and meta-regression of over 7.4 million participants.
    PLoS One. 2025;20:e0314661.
    PubMed     Abstract available
    
    
    
24. ABUBAKR K, Kennedy C, Al-Tikriti S, O'Higgins AC, et al
    Intrahepatic cholestasis of pregnancy and gestational diabetes: Protocol for a scoping review of associations, risk factors, and outcomes.
    PLoS One. 2025;20:e0300076.
    PubMed     Abstract available
    
    
    
25. GAO C, Liu M, Sun Y, Zhao Z, et al
    Association between advanced lung cancer inflammation index and gallstone prevalence among U.S. adults: A population-based study.
    PLoS One. 2025;20:e0321733.
    PubMed     Abstract available
    
    
    
26. TIAN L, Guo Q, Fu D, Ma X, et al
    Adjuvant chemotherapy compared with observation in patients with resected biliary tract cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0295583.
    PubMed     Abstract available
    
    
    
27. SAEHENG T, Tongsiri N, Na-Bangchang K
    The first validation of the Functional Assessment of Cancer Therapy Hepatobiliary (FACT-Hep) for evaluating health-related quality of life (HRQOL) in patients with advanced-stage intrahepatic cholangiocarcinoma (biliary tract cancer).
    PLoS One. 2025;20:e0321618.
    PubMed     Abstract available
    
    
    
28. YE J, Liu R, Wang J, Ma W, et al
    Association of albumin-bilirubin grade with survival outcomes in patients with cholangiocarcinoma.
    PLoS One. 2025;20:e0321758.
    PubMed     Abstract available
    
    
    
29. THANYAPHOO S, Sae-Lee C, Thaopech W, Amornrit W, et al
    Transcriptome insights into newcastle disease virus-mediated eradication of cholangiocarcinoma cells.
    PLoS One. 2025;20:e0322307.
    PubMed     Abstract available
    
    
    
30. WIN ZZ, Dokduang H, Kulwong S, Loilome W, et al
    Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma.
    PLoS One. 2025;20:e0322173.
    PubMed     Abstract available
    
    
    
31. OLFATIFAR M, Rajabnia M, Sadeghi A, Rabbani A, et al
    The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: An updated meta-analysis and modeling study.
    PLoS One. 2025;20:e0322479.
    PubMed     Abstract available
    
    
    
32. MARTVISET P, Chantree P, Tongsiri N, Plengsuriyakarn T, et al
    Targeting tumor-associated genes, immune response, and circulating tumor cells in intrahepatic cholangiocarcinoma: Therapeutic potential of Atractylodes lancea (Thunb.) DC.
    PLoS One. 2025;20:e0323732.
    PubMed     Abstract available
    
    
    
33. INOUE T, Masuda T, Koiso T, Ibusuki M, et al
    Heated-balloon ablation as a novel less invasive local treatment for bile duct strictures: A first experimental study.
    PLoS One. 2025;20:e0322801.
    PubMed     Abstract available
    
    
    
34. NGAMSANGIAM W, Techa-Ay S, Sa-Ngiamwibool P, Watcharadetwittaya S, et al
    Distinct chromosome abnormality patterns for differential diagnosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2025;20:e0322408.
    PubMed     Abstract available
    
    
    
35. NOGUCHI D, Kuriyama N, Kozuka Y, Komatubara H, et al
    A recent update on the morphological classification of intraductal papillary neoplasm of the bile duct: Correlation with postoperative prognosis and pathological features.
    PLoS One. 2025;20:e0325081.
    PubMed     Abstract available
    
    
    
36. SCHACHTSCHNEIDER KM, Redlon LN, Lokken RP, Huang YH, et al
    Epigenetic regulation of individual components of combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2025;20:e0324145.
    PubMed     Abstract available
    
    
    
37. FAIPAN A, Sitthirak S, Wangwiwatsin A, Namwat N, et al
    Mitochondrial genomic alterations in cholangiocarcinoma cell lines.
    PLoS One. 2025;20:e0323844.
    PubMed     Abstract available
    
    
    
38. XIONG Z, Sun Q, Huang J, Li F, et al
    Non-linear association of cardiometabolic index with gallstone disease in US adults: A cross-sectional study.
    PLoS One. 2025;20:e0328415.
    PubMed     Abstract available
    
    
    
39. WANG J, Qi X, Zhao W, Hao Z, et al
    Hsa_circ_0006834 represses intrahepatic cholangiocarcinoma proliferation through activating AMPK-mTOR pathway and autophagy via has-miR-637-NGFR network.
    PLoS One. 2025;20:e0329847.
    PubMed     Abstract available
    
    
    
40. CHEN X, Huang J, Chen X, Luo Q, et al
    Comparative analysis of differences for pathological upgrade and incomplete resection in endoscopic snare papillectomy for ampullary adenomas: A single-institution retrospective study.
    PLoS One. 2025;20:e0330220.
    PubMed     Abstract available
    
    
    
41. SHEN W, Liu Y, Dai B, Qin C, et al
    Downregulation of NCOA4 expression indicates poor prognosis and promotes the progression of cholangiocarcinoma.
    PLoS One. 2025;20:e0327722.
    PubMed     Abstract available
    
    
    
42. LYU C, Meng X, Wang J, Shao H, et al
    Optimized processing of Gardenia Fruits with ginger juice: Unveiling therapeutic mechanisms for cholestatic liver injury through TLR4/NF-kappaB, FXR/PPAR-alpha, and PI3K/AKT/GSK-3beta.
    PLoS One. 2025;20:e0330189.
    PubMed     Abstract available
    
    
    
43. LI J, Zhou YQ
    Enhanced gallbladder cancer detection via active and self-supervised learning integration: Innovating B-ultrasound image analysis.
    PLoS One. 2025;20:e0330781.
    PubMed     Abstract available
    
    
    
44. DU C, Wang H, Cao W, Yu Z, et al
    Perioperative and long-term outcomes of laparoscopic liver resection for combined hepatocellular carcinoma and cholangiocarcinoma versus intrahepatic cholangiocarcinoma: A propensity score matching analysis.
    PLoS One. 2025;20:e0328104.
    PubMed     Abstract available
    
    
    
45. MON AM, Intuyod K, Klungsaeng S, Jusakul A, et al
    A circulating microRNA panel enhances the diagnosis of cholangiocarcinoma.
    PLoS One. 2025;20:e0333279.
    PubMed     Abstract available
    
    
    
46. TANASUKA P, Thongpon P, Chomwong S, Kongsintaweesuk S, et al
    Suppression of kinesin family member-18A diminishes progression and induces apoptotic cell death of gemcitabine-resistant cholangiocarcinoma cells by modulating PI3K/Akt/mTOR and NF-kappaB pathways.
    PLoS One. 2025;20:e0334147.
    PubMed     Abstract available
    
    
    
47. SERRI R, Dehneh N, Ghannam M, Sirri MR, et al
    Synergistic effects of sesame oil, extra virgin olive oil, psyllium extract, and dandelion extract on cholesterol gallstone dissolution: An in vitro comparative study against Rowachol(R).
    PLoS One. 2025;20:e0334496.
    PubMed     Abstract available
    
    
    
48. CHAIDEE A, Kongsintaweesuk S, Pongking T, Tunbenjasiri K, et al
    Minimally invasive detection of early-stage opisthorchiasis-associated cholangiocarcinoma using label-free surface-enhanced Raman spectroscopy (SERS) of hamster serum.
    PLoS One. 2025;20:e0334916.
    PubMed     Abstract available
    
    
    
49. DAI J, Selvaraj E, Culver EL, Bailey A, et al
    Association between non-invasive biomarkers and quality of life in Primary Sclerosing Cholangitis.
    PLoS One. 2025;20:e0335642.
    PubMed     Abstract available
    
    
    
50. HEINRICH S, Ten Thoren PJ, Behrendt P, Hagenah J, et al
    Dynamic growth risk of incidentally detected gallbladder polyps-A retrospective, single-center analysis.
    PLoS One. 2025;20:e0337890.
    PubMed     Abstract available
    
    
    January 2024
51. LIU Z, Shao Y, Duan X
    Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298225.
    PubMed     Abstract available
    
    
    
52. DI CARLO P, Serra N, Fasciana TMA, Giammanco A, et al
    Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    PLoS One. 2024;19:e0294049.
    PubMed     Abstract available
    
    
    
53. BAGER P, Bossen L, Gantzel R, Gronbaek H, et al
    High-dose oral thiamine versus placebo for chronic fatigue in patients with primary biliary cholangitis: A crossover randomized clinical trial.
    PLoS One. 2024;19:e0301354.
    PubMed     Abstract available
    
    
    
54. GUPTA K, Xu JP, Diamond T, de Jong IEM, et al
    Low-dose biliatresone treatment of pregnant mice causes subclinical biliary disease in their offspring: Evidence for a spectrum of neonatal injury.
    PLoS One. 2024;19:e0301824.
    PubMed     Abstract available
    
    
    
55. BEKRIC D, Kiesslich T, Ocker M, Winklmayr M, et al
    The efficacy of ferroptosis-inducing compounds IKE and RSL3 correlates with the expression of ferroptotic pathway regulators CD71 and SLC7A11 in biliary tract cancer cells.
    PLoS One. 2024;19:e0302050.
    PubMed     Abstract available
    
    
    
56. ZHOU X, Huang T, Pan H, Du A, et al
    Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma.
    PLoS One. 2024;19:e0300441.
    PubMed     Abstract available
    
    
    
57. KIM SH, Lee S
    Determining the patency of biliary tracts in dogs with gallbladder mucocele using near-infrared cholangiography with indocyanine green.
    PLoS One. 2024;19:e0300395.
    PubMed     Abstract available
    
    
    
58. HUANG X, Gu H, Shen P, Zhang X, et al
    Systematic review and meta-analysis: Evaluating the influence of intrahepatic cholestasis of pregnancy on obstetric and neonatal outcomes.
    PLoS One. 2024;19:e0304604.
    PubMed     Abstract available
    
    
    
59. ALI K, Chervu NL, Sakowitz S, Bakhtiyar SS, et al
    Interhospital variation in the nonoperative management of acute cholecystitis.
    PLoS One. 2024;19:e0300851.
    PubMed     Abstract available
    
    
    
60. GOOKIN JL, Jewell DE, Aicher KM, Seiler GS, et al
    Increased lipogenesis and lipidosis of gallbladder epithelium in dogs with gallbladder mucocele formation.
    PLoS One. 2024;19:e0303191.
    PubMed     Abstract available
    
    
    
61. KERDKUMTHONG K, Nanarong S, Roytrakul S, Pitakpornpreecha T, et al
    Quantitative proteomics analysis reveals possible anticancer mechanisms of 5'-deoxy-5'-methylthioadenosine in cholangiocarcinoma cells.
    PLoS One. 2024;19:e0306060.
    PubMed     Abstract available
    
    
    
62. LI L, Liu C, Xia T, Li H, et al
    Association between plant-based dietary index and gallstone disease: A cross sectional study from NHANES.
    PLoS One. 2024;19:e0305822.
    PubMed     Abstract available
    
    
    
63. TANG G, Nierath WF, Leitner E, Xie W, et al
    Comparing animal well-being between bile duct ligation models.
    PLoS One. 2024;19:e0303786.
    PubMed     Abstract available
    
    
    
64. MANTAS A, Otto CC, Olthof PB, Heise D, et al
    Clinical features and prediction of long-term survival after surgery for perihilar cholangiocarcinoma.
    PLoS One. 2024;19:e0304838.
    PubMed     Abstract available
    
    
    
65. HAN X, Wang J, Wu Y, Gu H, et al
    Predictive value of bile acids as metabolite biomarkers for gallstone disease: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0305170.
    PubMed     Abstract available
    
    
    
66. KATSUMI T, Sato H, Murakami R, Hanatani T, et al
    Identification of microbial antigens in liver tissues involved in the pathogenesis of primary biliary cholangitis using 16S rRNA metagenome analysis.
    PLoS One. 2024;19:e0308912.
    PubMed     Abstract available
    
    
    
67. GOPAL SH, Zebda R, Mohan A, Borovsky K, et al
    Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0307837.
    PubMed     Abstract available
    
    
    
68. WATAD H, Ohayon A, Meyer R, Cohen A, et al
    Proteinuria is a clinical characteristic of intrahepatic cholestasis of pregnancy but it is not a marker of severity: A retrospective cohort study.
    PLoS One. 2024;19:e0310217.
    PubMed     Abstract available
    
    
    
69. PANYA A, Wathikthinnakon M, Thepmalee C, Chiawpanit C, et al
    Polysaccharide extract of Spirulina sp. increases effector immune-cell killing activities against cholangiocarcinoma.
    PLoS One. 2024;19:e0312414.
    PubMed     Abstract available
    
    
    
70. WANG T, Xie R, Jiang C, Chen L, et al
    Associations between Life's Essential 8 and gallstones among US adults: A cross-sectional study from NHANES 2017-2018.
    PLoS One. 2024;19:e0312857.
    PubMed     Abstract available
    
    
    
71. LI X, Wang J, Leng K
    Lipid accumulation product and gallstone risk in US adults: A cross-sectional analysis of NHANES 2017-2020 data.
    PLoS One. 2024;19:e0315235.
    PubMed     Abstract available
    
    
    
72. YU S, Kang M, Yoo Y, Kim TY, et al
    Characterization of an Enterococcus sp. SMC-9 strain isolated from bile of a patient with cholangitis.
    PLoS One. 2024;19:e0312953.
    PubMed     Abstract available
    
    
    
73. ANGENDOHR C, Missing L, Ehlting C, Wolf SD, et al
    Interleukin 1 beta suppresses bile acid-induced BSEP expression via a CXCR2-dependent feedback mechanism.
    PLoS One. 2024;19:e0315243.
    PubMed     Abstract available
    
    
    
74. SAHAT O, Kamsa-Ard S, Suwannatrai AT, Lim A, et al
    Spatial analysis of cholangiocarcinoma in Thailand from 2012 to 2021; a population-based cancer registries study.
    PLoS One. 2024;19:e0311035.
    PubMed     Abstract available
    
    
    January 2023
75. ZHOU T, Wei H, Wang J
    Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid.
    PLoS One. 2023;18:e0279431.
    PubMed     Abstract available
    
    
    
76. WONGKANONG C, Patumanond J, Ratanachu-Ek T, Junrungsee S, et al
    Development of clinical prediction rule for the requirement of endoscopic papillary large balloon dilation (EPLBD) on endoscopic CBD stone clearance.
    PLoS One. 2023;18:e0282899.
    PubMed     Abstract available
    
    
    
77. INOUE T, Kutsumi H, Ibusuki M, Yoneda M, et al
    Endoscopic biliary ethanol ablation using a novel multi-hole balloon catheter: In vivo feasibility study in a swine model.
    PLoS One. 2023;18:e0283733.
    PubMed     Abstract available
    
    
    
78. YANG S, Qin L, Wu P, Liu Y, et al
    RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation.
    PLoS One. 2023;18:e0283770.
    PubMed     Abstract available
    
    
    
79. YE Y, Lui VCH, Babu RO, Wu Z, et al
    Identification of cancer-related genes FGFR2 and CEBPB in choledochal cyst via RNA sequencing of patient-derived liver organoids.
    PLoS One. 2023;18:e0283737.
    PubMed     Abstract available
    
    
    
80. HAN X, Wang J, Wu Y, Gu H, et al
    Predictive value of bile acids as metabolite biomarkers for gallstones: A protocol of systematic review and meta-analysis.
    PLoS One. 2023;18:e0284138.
    PubMed     Abstract available
    
    
    
81. POUDEL SK, Padmanabhan R, Dave H, Guinta K, et al
    Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease.
    PLoS One. 2023;18:e0283021.
    PubMed     Abstract available
    
    
    
82. JANNONE G, de Magnee C, Tambucci R, Evraerts J, et al
    Premature senescence of the liver in Alagille patients.
    PLoS One. 2023;18:e0285019.
    PubMed     Abstract available
    
    
    
83. KIM MH, Lee EJ, Kim SJ, Jung YJ, et al
    Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression.
    PLoS One. 2023;18:e0287146.
    PubMed     Abstract available
    
    
    
84. SIDDIQUI MA, Dwivedi N, Siddiqui MH, Rana SV, et al
    NMR spectroscopy-based analysis of gallstones of cancerous and benign gallbladders from different geographical regions of the Indian subcontinent.
    PLoS One. 2023;18:e0286979.
    PubMed     Abstract available
    
    
    
85. MAYR C, Kiesslich T, Bekric D, Beyreis M, et al
    Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells.
    PLoS One. 2023;18:e0287769.
    PubMed     Abstract available
    
    
    
86. NEROLDOVA M, Ciara E, Slatinska J, Frankova S, et al
    Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.
    PLoS One. 2023;18:e0288907.
    PubMed     Abstract available
    
    
    
87. KUNIYOSHI N, Imazu H, Masuzaki R, Yamazaki M, et al
    Diagnostic utility of quantitative analysis of microRNA in bile samples obtained during endoscopic retrograde cholangiopancreatography for malignant biliary strictures.
    PLoS One. 2023;18:e0289537.
    PubMed     Abstract available
    
    
    
88. IWAMOTO T, Suda T, Inoue T, Nozaki Y, et al
    Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy.
    PLoS One. 2023;18:e0288463.
    PubMed     Abstract available
    
    
    
89. SHEARN CT, Anderson AL, Devereaux MW, El Kasmi KC, et al
    Expression of circadian regulatory genes is dysregulated by increased cytokine production in mice subjected to concomitant intestinal injury and parenteral nutrition.
    PLoS One. 2023;18:e0290385.
    PubMed     Abstract available
    
    
    
90. GOINS EC, Wein LE, Watkins VY, Campbell AIK, et al
    Maternal and neonatal outcomes in patients with hepatitis C and intrahepatic cholestasis of pregnancy: The sum of the parts.
    PLoS One. 2023;18:e0293030.
    PubMed     Abstract available
    
    
    
91. PHAM HN, Pham L, Sato K
    Bioinformatic analysis identified novel candidate genes with the potentials for diagnostic blood testing of primary biliary cholangitis.
    PLoS One. 2023;18:e0292998.
    PubMed     Abstract available
    
    
    
92. HAYASHI H, Shimizu A, Kubota K, Notake T, et al
    Impact of sarcopenic obesity on post-hepatectomy bile leakage for hepatocellular carcinoma.
    PLoS One. 2023;18:e0286353.
    PubMed     Abstract available
    
    
    
93. YUK JS, Park JY
    Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
    PLoS One. 2023;18:e0294356.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum